» Articles » PMID: 36569661

Association Between ABO Blood Group and Gestational Diabetes Mellitus in Pregnant Women at King Abdulaziz University Hospital: A Retrospective Study

Overview
Journal Cureus
Date 2022 Dec 26
PMID 36569661
Authors
Affiliations
Soon will be listed here.
Abstract

Objective Gestational diabetes mellitus (GDM) can occur during pregnancy. One of the leading causes of it is a hormone produced by the placenta that interferes with glucose absorption and causes glucose buildup in the bloodstream. Genetic variations between ethnicities are believed to be associated with GDM, and there has been some research on the association of ABO blood group with GDM in different populations. However, the results so far are inconsistent, and there is no conclusive evidence on how ABO blood group affects the occurrence of GDM. This study aims to examine the link between ABO blood group and GDM in pregnant women at King Abdulaziz University Hospital. Methodology A retrospective cohort study was conducted on a group of GDM patients between 2019 and 2022 using data collected from the patients' medical records at King Abdulaziz University Hospital. Results The overall prevalence of GDM was high at 74.7%, and the percentage of patients with A, O, B, and AB blood group who had GDM was 42.9%, 41.41%, 12.1%, and 3.59%, respectively. However, there was no significant difference in Rh status or any other clinical characteristic between the participants who had GDM and those who did not have GDM. Conclusion The present findings indicate that blood group is not associated with the development of GDM in this cohort from Saudi Arabia. However, more studies are required in the future to corroborate these findings.

Citing Articles

Prevalence and Risk Factors of Confirmed Gestational Diabetes Mellitus Among Pregnant Women With Prior Positive Screening: A Case-Control Study.

Ghamri K Cureus. 2024; 16(5):e61216.

PMID: 38939238 PMC: 11208977. DOI: 10.7759/cureus.61216.


ABO blood groups are not associated to gestational diabetes mellitus in Mexican women.

Cordero-Franco H, Salinas-Martinez A, Esparza-Contro M, Gonzalez-Rueda S, Guzman-de la Garza F PLoS One. 2023; 18(10):e0292493.

PMID: 37844033 PMC: 10578575. DOI: 10.1371/journal.pone.0292493.

References
1.
Franchini M, Lippi G . The intriguing relationship between the ABO blood group, cardiovascular disease, and cancer. BMC Med. 2015; 13:7. PMC: 4295232. DOI: 10.1186/s12916-014-0250-y. View

2.
Muche A, Olayemi O, Gete Y . Gestational diabetes mellitus increased the risk of adverse neonatal outcomes: A prospective cohort study in Northwest Ethiopia. Midwifery. 2020; 87:102713. DOI: 10.1016/j.midw.2020.102713. View

3.
Franchini M, Favaloro E, Targher G, Lippi G . ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit Rev Clin Lab Sci. 2012; 49(4):137-49. DOI: 10.3109/10408363.2012.708647. View

4.
Zhang C, Li Y, Wang L, Sun S, Liu G, Leng J . Blood group AB is protective factor for gestational diabetes mellitus: a prospective population-based study in Tianjin, China. Diabetes Metab Res Rev. 2015; 31(6):627-37. DOI: 10.1002/dmrr.2650. View

5.
Liumbruno G, Franchini M . Beyond immunohaematology: the role of the ABO blood group in human diseases. Blood Transfus. 2013; 11(4):491-9. PMC: 3827391. DOI: 10.2450/2013.0152-13. View